Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. - Test2 - elhamkhani - TriplyDB

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

http://www.wikidata.org/entity/Q44573505

about

Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea.Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.Emergence of Community-Genotype Methicillin-Resistant Staphylococcus aureus in Korean Hospitals: Clinical Characteristics of Nosocomial Infections by Community-Genotype Strain.The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia.Spectrum of early-onset and late-onset bacteremias after liver transplantation: implications for management Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study.Predictors of mortality in Staphylococcus aureus Bacteremia Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study The value of infectious diseases consultation in Staphylococcus aureus bacteremia Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients.Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.Pneumonia caused by methicillin-resistant Staphylococcus aureus.Methicillin-resistant Staphylococcus aureus pneumonia in adults.agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis.agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome.Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.Coagulase-negative staphylococcal bacteremia: risk factors for mortality and impact of initial appropriate antimicrobial therapy on outcome.Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study.Serum capacity to neutralize superantigens does not affect the outcome of Staphylococcus aureus bacteremia.Crystal structures of the Apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus.Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients.Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.Early detection of systemic infections.Methicillin-sensitive Staphylococcus aureus bacteremia in aged patients: the importance of formal infectious specialist consultation.

P2860

Q31101980-394F662E-A135-4F95-9176-D3F72B5FA0DF Q33803393-D35853CC-AB75-4E5E-9B9D-628CCCE97C81 Q33880391-1D998938-2459-4351-8A29-579360E7993E Q34091829-7DA3F2CA-149C-453B-B21A-85CCFD38B98E Q34288755-E0A1D69C-64CF-4ADF-8725-5AC6075878C4 Q34447860-F9008882-3C48-47BC-8D35-BC7C0580F02B Q34928386-27F1A2A0-CECD-443B-B620-959A01966766 Q35011986-C22F69F9-A10D-4086-98D9-9D1B7B47C9BF Q35077842-727E12BD-AC2E-42F1-859D-FEAC40E4C364 Q35153754-B2AEDC84-0737-4023-A784-FA4798E06FDB Q35940556-DCA8E59C-B224-4E05-8DE3-814E31A26A36 Q36422681-71F9514E-B23B-406B-8BB1-FFD5769C1C88 Q36565826-310EDE69-258B-4C45-828F-35797614517D Q36710238-D5A28FC4-D988-4343-9578-98EAE0D98052 Q36847287-21C9BA7A-FCCE-4A26-9C16-8D0D5C9AE259 Q36864125-912D29FB-AF3C-44F6-A621-65571C9BA304 Q37116605-54D8B620-3181-4A22-909E-6D8B37E0940E Q37156705-B6EB8F8B-CC53-44DD-825C-0F87D08EA0BF Q38230203-AF5C443C-A427-471B-A053-6874D862CCB6 Q38457418-D9BADF16-560B-44B5-9F36-35B1E1676D06 Q38460185-C87029A2-1C89-4614-A4EA-13FCD659E689 Q40162501-63FE6CD6-AC96-4E1A-B9B2-F8475951E54C Q40491682-53A66C7F-7347-49E1-9D48-FFB758B6F954 Q40515287-74060D2A-C612-4D99-A083-B7213F1F226D Q41366262-52C86B33-1051-4AE7-A2A9-9964A2328E36 Q42220885-E373F311-1C2F-4BF2-B2A9-2A6326BEE43F Q43497971-B23C1A95-6052-4E15-BCD5-A3E3EBC027C1 Q45024980-68950BE8-CC5B-4F13-B4C3-9834AAD07F16 Q45908851-B05D0A9A-E643-4872-929C-193C950D2A81 Q46899628-32FA1F6B-23F4-44CA-A3F8-FB2B12648CB9 Q53424473-5D8B9143-B492-4196-8E2E-568CF113C700 Q53898899-94017C9F-556A-4BA0-BE9A-5520D1D35A15 Q55379607-554D361C-7848-4703-ADE6-53E49380F7D4

P2860

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

http://www.wikidata.org/entity/Q44573505

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@en

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@nl

type

label

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@en

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@nl

prefLabel

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@en

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@nl

P1433

Q44573505-5E86169C-F081-426B-8941-08456FFAB395

P1476

Q44573505-E2DD6B50-9462-4F47-9864-58B5732851E0

P2093

Q44573505-05C673DB-8B63-4394-B871-B5052AF73B30

Q44573505-0DE7BE26-50B3-4B8E-9B9B-B75EA7833EBF

Q44573505-31C117A9-1FBB-476C-8F15-7519B0232805

Q44573505-AA713D08-B9E2-4E08-95CF-E0C69301389D

Q44573505-D66A0581-2783-40D0-8E8C-C007386B0F2B

Q44573505-DF439EBA-B680-40EF-A63C-F71853EFE5B4

P304

Q44573505-44FF0743-8A68-4DD8-AB66-C24D44322B59

P31

Q44573505-AF634DA6-67C6-4290-A56B-2E3CEFF3F1C0

P356

Q44573505-227179C2-6391-49F4-BE46-B1319ABB8CC4

P407

Q44573505-DE022184-9F20-49B7-AFBC-270FB2973C2B

P433

Q44573505-8B781AED-74BF-45DC-8FED-369BB38B6011

P478

Q44573505-9F831864-6676-46DB-8801-80FB9CC1CF58

P50

Q44573505-48FA7FB2-167C-4C07-901F-1DCC5855441C

Q44573505-8066D489-2AF1-4DCF-9F7E-DB4738F5EAD9

P577

Q44573505-F2E7F987-A7E3-494C-9A48-DB26480F8F1A

P5875

Q44573505-624690D3-C753-465C-A31F-B7F4319081DC

P698

Q44573505-F314272C-B43D-42E0-94EF-6654DC615345

P356

P1433

Clinical Infectious Diseases

P1476

Outcome of Staphylococcus aure ...... oci versus noneradicable foci.

@en

P2093

Cheol-In Kang

http://www.w3.org/2001/XMLSchema#string

Eui-Chong Kim

http://www.w3.org/2001/XMLSchema#string

Hong-Bin Kim

http://www.w3.org/2001/XMLSchema#string

Kang-Won Choe

http://www.w3.org/2001/XMLSchema#string

Ki-Deok Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Han Kim

http://www.w3.org/2001/XMLSchema#string

P304

794-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/377540

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10582160

http://www.w3.org/2001/XMLSchema#string

P698

12955640

http://www.w3.org/2001/XMLSchema#string